10-Q: AMJ Global Technology Faces Going Concern Warning Amidst Zero Revenue and Mounting Deficit; Strategic Pivots and Related Party Deals Dominate Quarterly Report

Sentiment:

Quarterly Report


AMJ Global Technology reported a significant net loss and a going concern warning for the quarter ended February 28, 2025, as it continues to operate without revenue, relying heavily on related party financing and navigating strategic shifts.

Delay expectedThe Software Purchase and Development agreement dated August 25, 2024, for an 8% interest in ElephantSqlDB, was terminated via an unwinding agreement on May 7, 2025, with shares returned to treasury.The Stock Purchase Agreement dated January 27, 2025, with JP Michael LLC for a share exchange, was unwound and terminated on May 7, 2025, as the transactions had not been completed by February 28, 2025.
Capital raiseThe company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships.The $1,000,000 acquisition of equity interest in 'Target' from a related party includes a payment term of two years with a four-month extension, and the seller has agreed to take any outstanding unpaid balance in restricted stock of the company at $1.00 per share if not paid in cash.
Worse than expectedThe company reported zero revenue for the quarter, consistent with previous periods, indicating no progress in generating income from operations.Net loss increased to $55,362, contributing to a growing accumulated deficit of $531,636.Cash on hand is critically low at $77, and the working capital deficiency worsened to $242,858.The explicit 'going concern' warning from management and auditors highlights severe financial instability.Management concluded that disclosure controls and procedures were 'not effective', indicating significant internal control weaknesses.

Summary

  • AMJ Global Technology reported no operating revenues for the three months ended February 28, 2025, and February 29, 2024.
  • The company incurred a net loss of $55,362 for the three months ended February 28, 2025, an increase from $49,674 for the same period in the prior year.
  • Total assets significantly increased to $889,799 as of February 28, 2025, from $9,253 as of November 30, 2024, primarily due to a large equity investment in a related party.
  • Total liabilities also surged to $1,133,836 as of February 28, 2025, from $200,928, driven by a new $890,621 loan payable to a related party for the equity investment.
  • The company's accumulated deficit grew to $531,636 as of February 28, 2025, from $476,274.
  • A working capital deficiency of $242,858 was reported as of February 28, 2025, worsening from $195,422.
  • Cash on hand decreased to $77 as of February 28, 2025, from $226 as of November 30, 2024.
  • Net cash used in operating activities for the three months ended February 28, 2025, was $13,378, an improvement from $28,250 in the prior year, but still negative.
  • The company's continuation as a going concern is dependent on its ability to generate revenues and secure additional investment capital and loans from related parties.
  • Subsequent to the quarter end, the company unwound a software purchase agreement for an 8% interest in ElephantSqlDB and a share exchange agreement with JP Michael LLC.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to the explicit going concern warning, zero revenue, increasing net loss, critically low cash balance, worsening working capital deficiency, and ineffective internal controls. While there are strategic efforts, the financial foundation is highly unstable, and key agreements have been unwound.

Positives

  • Net cash used in operating activities decreased to $13,378 for the three months ended February 28, 2025, from $28,250 in the prior year, indicating a reduced cash burn from operations.
  • The company recognized $197 in equity investment income from related parties during the quarter.

Negatives

  • The company reported zero operating revenues for the current and prior comparable periods.
  • Net loss increased to $55,362 for the three months ended February 28, 2025, from $49,674 in the prior year.
  • Cash on hand is critically low at $77 as of February 28, 2025.
  • The accumulated deficit has grown to $531,636, and the working capital deficiency worsened to $242,858.
  • The company's auditors have issued a going concern opinion, raising substantial doubt about its ability to continue operations.
  • Disclosure controls and procedures were deemed not effective by management, indicating a significant internal control weakness.
  • The company is heavily reliant on advances and loans from related parties for its operations.

Risks

  • Substantial doubt exists about the company's ability to continue as a going concern due to its accumulated deficit and reliance on external funding.
  • The company has not generated any operating revenues, posing a significant risk to its long-term viability.
  • Heavy dependence on related party advances and loans for working capital, with no formal written commitment for continued support.
  • Inability to secure additional funding through private equity offerings, convertible notes, or strategic partnerships could impair business plan implementation.
  • Ineffective disclosure controls and procedures increase the risk of material information not being timely reported or summarized.
  • The unwinding of key strategic agreements (software interest, share exchange) indicates potential challenges in executing business development initiatives.

Future Outlook

The company is currently evaluating new operational ventures in the wholistic health industry, revenue sharing generated from Medicare enrollees, and life and annuity insurance sales, with the expectation that these will generate future revenue and cash flow. The company plans to seek additional financing through private equity offerings, convertible notes payable, and/or strategic partnerships to secure working capital for its operations.

Management Comments

  • "Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified."
  • "The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships."
  • "This operation [evaluating wholistic health, Medicare revenue sharing, life and annuity insurance sales] will generate revenue and cashflow for the Company."

Industry Context

AMJ Global Technology operates as a highly diversified start-up, attempting to establish a presence across disparate sectors including mobile software, holistic health, AI/quantum computing database technology, and insurance sales. This broad and unfocused strategy, coupled with a lack of revenue generation and significant financial distress, is characteristic of a very early-stage venture or a shell company seeking a viable business model. The recent unwinding of key strategic agreements (software interest, share exchange) suggests challenges in executing these diverse initiatives, which is a common hurdle for companies attempting rapid pivots without established operational foundations.

Comparison to Industry Standards

  • AMJ Global Technology's financial performance, characterized by zero revenue, increasing net losses, and a significant accumulated deficit, falls far below typical industry standards for operational stability and profitability in any of the sectors it aims to enter (technology, health, insurance).
  • The company's reliance on related party financing for its operations is a deviation from the self-sustaining financial models of established industry players, who typically fund growth through retained earnings, traditional debt, or public equity markets.
  • The explicit 'going concern' warning and the conclusion that disclosure controls and procedures are 'not effective' highlight severe deficiencies in financial health and corporate governance that are not aligned with best practices or regulatory expectations for mature companies.
  • Unlike successful companies that demonstrate clear market traction and scalable business models, AMJ Global Technology's repeated strategic pivots and the unwinding of significant agreements suggest a struggle to find a sustainable and revenue-generating path, making direct comparisons to established, profitable entities in its target industries difficult.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Independent Registered Public Accounting FirmGreen Growth, CPABarton CPA PLLC2025-03-05Dismissal of previous firm and engagement of new firm.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control EffectivenessManagement concluded that disclosure controls and procedures were not effective to provide reasonable assurance of timely alerting them to material information and ensuring information is recorded, processed, summarized, and reported within specified time periods.2025-02-28This indicates a material weakness in internal controls, posing a risk to the accuracy and timeliness of financial reporting and investor confidence.
Auditor ChangeThe company dismissed Green Growth, CPA and engaged Barton CPA PLLC as its independent registered public accounting firm.2025-03-05This change may reflect efforts to improve financial oversight or address previous audit concerns, but the impact on financial reporting quality remains to be seen.

Related Party Transactions

  • The company's CEO and director controls AMJ Global Entertainment, LLC, which is a significant related party.
  • On April 26, 2023, AMJ Global Entertainment, LLC assigned 25% of the ownership rights to the Blabeey platform intellectual property to the company at zero cost.
  • The company acquired a 5% equity stake and revenue sharing agreement in 'Target', a company controlled by a related party, on July 13, 2024, in exchange for 133,334 common shares.
  • On January 24, 2025, the company acquired 100% of AMJ Global Entertainment, LLC's 25% equity interest in 'Target' for $1,000,000, financed by a loan from AMJ Global Entertainment, LLC.
  • AMJ Global Entertainment, LLC advanced $10,483 to the company and repaid $303 during the three months ended February 28, 2025.
  • The company recognized $30,000 in management compensation from a related party during the quarter.
  • Office rent expenses of $1,500 were paid to a company controlled by a related party.
  • As of February 28, 2025, the company owed $26,346 in current advances and $1,000,000 in a non-current loan to AMJ Global Entertainment, LLC.

Stakeholder Impact

  • Shareholders face significant risk of dilution from potential future capital raises and a high risk of investment loss due to the company's going concern status and lack of revenue.
  • Management and related parties, particularly the CEO-controlled AMJ Global Entertainment, LLC, have substantial financial exposure and control over the company through loans and equity investments.
  • Creditors, primarily related parties, face repayment risk given the company's current financial distress and reliance on future funding.
  • Employees (if any beyond management) face job insecurity due to the company's unstable financial position and going concern warning.

Next Steps

  • Generate revenues from new operational ventures in the wholistic health industry, Medicare enrollees revenue sharing, and life and annuity insurance sales.
  • Secure additional working capital from investors through common stock, convertible notes payable, and/or strategic partnerships.
  • Address and improve the effectiveness of disclosure controls and procedures.

Key Dates

DateDescription
2013-08-16Company incorporated under the laws of the State of Nevada, originally as Kange Corp.
2017Company began focusing on the intersection of technology and wholistic technology-based health treatments.
2023-04-22Company filed a Certificate of Amendment to its Articles of Incorporation, changing its name to AMJ Global Technology.
2023-04-26Company entered into an assignment agreement with AMJ Global Entertainment, LLC to acquire 25% ownership rights to the Blabeey platform intellectual property at zero cost.
2024-07-13Company entered into a Revenue Sharing agreement with a related party ('Target') for acquisition of 5% of Target's issued and outstanding stock, entitling the company to 5% of net revenue from two Medicare contracts.
2024-08-25Company entered into a Software Purchase and Development agreement with Dataark Systems LLC to acquire an 8% interest in ElephantSqlDB database software.
2024-11-30Balance sheet date for the prior fiscal year.
2025-01-24Company entered into a binding Letter of Intent with AMJ Global Entertainment, LLC to acquire 100% of its 25% equity interest in 'Target' for $1,000,000.
2025-01-27Company entered into a share exchange agreement with JP Michael LLC to sell 5,000,000 shares of common stock for 2,000,000 shares of Diamond Lake Mineral, Inc. common stock.
2025-02-28End of the current quarterly reporting period.
2025-03-03Company's Annual Report on Form 10-K for the year ended November 30, 2024, was filed with the SEC.
2025-03-05Company dismissed Green Growth, CPA as its independent registered public accounting firm and engaged Barton CPA PLLC.
2025-03-08Company entered into an advisory board member agreement with compensation of 20,000 shares of common restricted stock.
2025-03-17Company entered into a subscription agreement for 3,000 shares of common restricted stock at $1.00 per share.
2025-03-17One of the company's stockholders returned 2,000 shares of common stock to the company's treasury.
2025-03-183,000 shares of common restricted stock were issued from the subscription agreement.
2025-03-1820,000 shares of common restricted stock were issued for the advisory board member agreement.
2025-05-07Company entered into an unwinding agreement to terminate the Software Purchase and Development agreement dated August 25, 2024, resulting in the cancellation of 1,333,333 common shares.
2025-05-07Both parties agreed to unwind and terminate the share exchange agreement dated January 27, 2025.
2025-05-08The company had 106,472,857 shares of common stock outstanding.
2025-05-28Date of filing of the Form 10-Q.

Recommendation

strong sell

Keywords

AMJ Global Technology, 10-Q, Quarterly Report, SEC filing, Going Concern, Financial Results, Net Loss, Related Party Transactions, Equity Investment, Working Capital Deficiency, Internal Controls, Start-up, Mobile Software, Wholistic Health, Medicare Revenue Sharing, ElephantSqlDB, Blabeey Platform

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.